Acasti Pharma Inc. (17)

Browse by Contract Category

Contracts

Form of Grace Therapeutics Inc. First Amendment to the Stockholders Agreement (Filed With SEC on July 1, 2021)
Form of 2017 Amended and Restated Convertible Promissory Note (Filed With SEC on July 1, 2021)
Independent contractor agreement with PFC Business Advisory Services Inc. dated September 14, 2020, and amended March 15, 2021, and June 16, 2021 (Filed With SEC on June 22, 2021)
Acasti Pharma Inc., Equity Incentive Plan, as amended August 27, 2020 (Filed With SEC on June 22, 2021)
Agreement and Plan of Merger, dated as of May 7, 2021, by and among Acasti, Grace and MergerCo (Filed With SEC on May 7, 2021)
Form of Grace Therapeutics Inc. Stockholders Agreement (Filed With SEC on July 1, 2021)
Form of Second Amendment to 2018 Convertible Note Purchase Agreements and Amendment to Convertible Promissory Notes (Filed With SEC on July 1, 2021)
Form of Amendment to 2018 Convertible Note Purchase Agreements (Filed With SEC on July 1, 2021)
Form of Amendment to 2017 Convertible Note Purchase Agreement and Amended and Restated Convertible Promissory Notes (Filed With SEC on July 1, 2021)
Form of 2017 Convertible Note Purchase Agreement (Filed With SEC on July 1, 2021)
Form of 2018 Convertible Note Purchase Agreement (Filed With SEC on July 1, 2021)
Form of 2017 Convertible Promissory Note (Filed With SEC on July 1, 2021)
Form of 2018 Convertible Promissory Note (Filed With SEC on July 1, 2021)
Acasti Pharma Inc., Stock Option Plan, as amended August 27, 2020 (Filed With SEC on June 22, 2021)
Form of Voting Agreement by and between Acasti and each of the Specified Grace Stockholders (Filed With SEC on May 7, 2021)
Retention agreement, dated October 29, 2020 between Acasti Pharma Inc. and Pierre Lemieux (Filed With SEC on November 16, 2020)
Retention agreement, dated October 27, 2020, between Acasti Pharma Inc. and Jan DAlvise (Filed With SEC on November 16, 2020)